Topical Anti-TNF[alpha] Agent Licaminlimab Relieves Persistent Ocular Discomfort in Severe Dry Eye Disease: A Randomized Phase II Study

Purpose: To assess the efficacy, safety, and pharmacokinetics of new topical ocular anti-TNF[alpha] antibody fragment licaminlimab in the relief of persistent ocular discomfort in severe dry eye disease (DED). Patients and Methods: Patients with [greater than or equal to] 6-month history of DED, reg...

Celý popis

Podrobná bibliografia

Vydané v:	Clinical ophthalmology (Auckland, N.Z.) Ročník 16; s. 2167
Hlavní autori:	Shettle, Lee, McLaurin, Eugene, Martel, Joseph, Seaman, John W., III, Weissgerber, Georges
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Dove Medical Press Limited 31.07.2022
Predmet:	Antibodies Diabetic retinopathy Medical research Medicine, Experimental Ophthalmic drugs Ophthalmology Tumor necrosis factor Viral antibodies
ISSN:	1177-5483
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!